Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S 38844 dose-initiation and titration study in chronic heart failure
2013-003000-39Phase 2Completed
- Sponsor
- Servier
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of S38844 in chronic heart failure (CHF) and left ventricular systolic dysfunction (LVSD) (3 arms), sponsored by Servier. Started Feb 2014; status: completed.
02
Drugs
S38844
03
Conditions
chronic heart failure (CHF)left ventricular systolic dysfunction (LVSD)
Beyond the preview
Go deeper on 2013-003000-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003000-39.